EnsoHST
FDA-cleared, multi-night home sleep test for scalable sleep disorder diagnosis
Company profile
Company profile
EnsoData is a health AI company specializing in waveform intelligence and sleep diagnostics. The company has developed an AI-driven ecosystem that powers sleep medicine from diagnosis through long-term patient care, serving over 500 sleep clinics and analyzing more than 2.8 million sleep studies. EnsoData's flagship products include EnsoHST, an FDA-cleared multi-night home sleep test that enables scalable sleep disorder diagnosis; EnsoSleep, an AI-assisted sleep scoring solution that automates polysomnography (PSG) and home sleep apnea test (HSAT) analysis; EnsoHub, a unified platform for accessing and reviewing AI-scored sleep studies; and Therapy Track for long-term therapy monitoring. The company's technology is built on one of the largest waveform databases in the world, enabling it to extract clinical insights from physiological signals. EnsoData's mission is to harness data to make healthcare more accurate, efficient, and affordable, with a particular focus on addressing the estimated 54 million Americans and 936 million people globally who suffer from sleep apnea, 80% of whom remain undiagnosed. Beyond sleep, the company's research aims to find hidden intelligence in waveforms to diagnose, monitor, and intercept various disease states including heart disease, diabetes, mental health disorders, seizure disorders, and neurodegenerative conditions.
Company description EnsoData official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Hybrid deployment with recorded integration context.
Company milestones
Analyzed 2.8+ million sleep studies, serving 500+ sleep clinics, supporting 100,000+ patients monthly. Four FDA clearances obtained. Expanded product line to include full diagnostic-to-therapy pathway.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
FDA-cleared, multi-night home sleep test for scalable sleep disorder diagnosis
Unified platform to access, review and edit all AI-scored sleep studies
FDA-cleared AI-assisted sleep scoring and analysis solution
Long-term therapy monitoring extending the sleep care pathway
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · Feb 17, 2026
Emergency Physician Employer Market Share and Concentration by Ownership Type.Annals of emergency medicine · Jan 1, 2026
Association between positive airway pressure therapy and healthcare costs among older adults with comorbid obstructive sleep apnea and common chronic conditions: an actuarial analysis.Sleep · Sep 9, 2025
Strengths, weaknesses, opportunities, and threats of using AI-enabled technology in sleep medicine: a commentary.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · Jul 1, 2024
Association of hypoglossal nerve stimulator response with machine learning identified negative effort dependence patterns.Sleep & breathing = Schlaf & Atmung · May 1, 2023
Artificial intelligence and sleep: Advancing sleep medicine.Sleep medicine reviews · Oct 1, 2021
Clinical validation
No linked records are currently available.
Regulatory
K231355 · 510k · Feb 9, 2024
EnsoSleepK210034 · 510k · Jun 16, 2021
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
EnsoHST home sleep testing
EnsoHST diagnostic accuracy
Comparison to traditional methods
Valley Sleep Center case study
EnsoSleep automation for RPSGTs
Controlling quality and eliminating inconsistencies in reporting
40 physicians no longer complain about inconsistencies, improved efficiency and quality
Freeing up time to enhance patient care and develop new programs
Time freed to enhance patient care, develop new programs, build physician relationships, improve quality reporting
Enabling comparative data analysis across baseline and therapy nights
Ability to run baseline followed by therapy night with comparative data analysis
Eliminating study backlog and reducing patient wait times
Cutting into backlog, much shorter patient wait times for results
Improving patient testing and diagnostic workflow with cloud-based platform
Improved patient testing and diagnostic workflow, sleep lab running more smoothly
Reducing costs and processing time while improving scalability
Decreased costs, decreased processing time, improved physician buy-in regarding accuracy, increased scalability
Moving beyond legacy HSAT solutions to expand patient care and add new locations
30% growth in HSAT program, added cash-pay option, expanded to new locations without increasing staff
Improving turnaround time and patient setup efficiency
Great and efficient turnaround time, smooth and easy patient setup process
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on EnsoData's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.